Male endocrine dysfunction

Urologic Clinics of North America

Volumn 41, Issue 1, 2014, Pages 39-53

  Hotaling, James M ^a   Patel, Zamip ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Dysfunction; Endocrine; Fertility; Hypogonadism; Male; Review; Sperm; Spermatogenesis

Indexed keywords

DYSFUNCTION; ENDOCRINE; FERTILITY; HYPOGONADISM; MALE; REVIEW; SPERM; SPERMATOGENESIS;

ENDOCRINE SYSTEM DISEASES; GENETIC THERAPY; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IATROGENIC DISEASE; INFERTILITY, MALE; MALE; PROLACTIN; RELAXIN; TESTICULAR DISEASES; TESTIS;

EID: 84888304055     PISSN: 00940143     EISSN: 1558318X     Source Type: Journal    
DOI: 10.1016/j.ucl.2013.08.010     Document Type: Review

References (115)

1. Sigman M., Jarrow J.P. Male infertility. Campbell-Walsh urology 2007, vol. I:609-653. Saunders Elsevier Press, 6. 10th edition.
2. Krausz C. Male infertility: pathogenesis and clinical diagnosis. Best Pract Res Clin Endocrinol Metab 2011, 25(2):271-285.
3. Liu P.Y., Handelsman D.J. The present and future state of hormonal treatment for male infertility. Hum Reprod Update 2003, 9(1):9-23.
4. O'Shaughnessy P.J., Verhoeven G., De Gendt K., et al. Direct action through the Sertoli cells is essential for androgen stimulation of spermatogenesis. Endocrinology 2010, 151(5):2343-2348.
5. Coviello A.D., Bremner W.J., Matsumoto A.M., et al. Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen. JAndrol 2004, 25(6):931-938.
6. Kim H., Schlegal P. Endocrine manipulation in male infertility. Urol Clin North Am 2008, 35(2):303-318.
7. Baker H.W., Santen R.J., Burger H.G., et al. Rhythms in the secretion of gonadotropins and gonadal steroids. JSteroid Biochem 1975, 6(5):793-801.
8. Gonzales G.F., Risbridger G.P., de Krester D.M. Invivo and invitro production of inhibin by cryptorchid testes from adult rats. Endocrinology 1989, 124(4):1661-1668.
9. Meehan T., Schlatt S., O'Bryan M.K., et al. Regulation of germ cell and Sertoli cell development by activin, follistatin, and FSH. Dev Biol 2000, 220(2):225-237.
10. Anderson R.A., Evans L.W., Irvine D.S., et al. Follistatin and activin A production by the male reproductive tract. Hum Reprod 1998, 13(12):3319-3325.
11. Levallet J., Pakarinen P., Huhtaniemi I.T. Follicle-stimulating hormone ligand and receptor mutations, and gonadal dysfunction. Arch Med Res 1999, 30(6):486-494.
12. Gerlo S., Davis J.R., Mager D.L., et al. Prolactin in man: a tale of two promoters. Bioessays 2006, 28(10):1051-1055.
13. Mangurian L.P., Walsh R.J., Posner B.I. Prolactin enhancement of its own uptake at the choroids plexus. Endocrinology 1992, 131(2):698-702.
14. Grattan D.R. The actions of prolactin in the brain during pregnancy and lactation. Prog Brain Res 2001, 133:153-171.
15. Aleem M., Padwal V., Choudhary J., et al. Sperm protamine levels as indicators of fertilising potential in sexually mature male rats. Andrologia 2008, 40(1):29-37.
16. Gill-Sharma M.K. Prolactin and male fertility: the long and short feedback regulation. Int J Endocrinol 2009, 2009:687259.
17. Jain S.K., Zelena D. Role of ionotropic glutamate receptors in the control of prolactin secretion by other neurotransmitters and neuropeptides at the level of the pituitary. Endocr Regul 2013, 47(2):65-74.
18. Galdiero M., Pivonello R., Grasso L.F., et al. Growth hormone, prolactin, and sexuality. JEndocrinol Invest 2012, 35(8):782-794.
19. Melmed S., Polonsky K.S., Larsen P.R. Williams Textbook of Endocrinology 2011, Elsevier Saunders, Philadelphia.
20. Wren A.M., Small C.J., Ward H.L., et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000, 141(11):4325-4328.
21. Meinhardt U.J., Ho K.K. Modulation of growth hormone action by sex steroids. Clin Endocrinol (Oxf) 2006, 65(4):413-422.
22. Addison M.L., Rissman E.F. Sexual dimorphism of growth hormone in the hypothalamus: regulation by estradiol. Endocrinology 2012, 153(4):1898-1907.
23. Scarth J.P. Modulation of the growth hormone-insulin-like growth factor (GH-IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: an emerging role for xenobiotic-metabolizing enzymes and the transcription factors regulating their expression. A review. Xenobiotica 2006, 36(2-3):119-218.
24. Wong A.O., Zhou H., Jiang Y., et al. Feedback regulation of growth hormone synthesis and secretion in fish and the emerging concept of intrapituitary feedback loop. Comp Biochem Physiol A Mol Integr Physiol 2006, 144(3):284-305.
25. Ivell R., Kotula-Balak M., Glynn D., et al. Relaxin family peptides in the male reproductive system-a critical appraisal. Mol Hum Reprod 2011, 17:71-84.
26. Anand-Ivell R., Dai Y., Ivell R. Neohormones as biomarkers of reproductive health. Fertil Steril 2013, 99(4):1153-1160.
27. Ivell R., Anand-Ivell R. The biology of insulin-like factor 3 (INSL3) in human reproduction. Hum Reprod Update 2009, 15:463-476.
28. Anand-Ivell R., Heng K., Hafen B., et al. Dynamics of INSL3 peptide expression in the rodent testis. Biol Reprod 2009, 81:480-487.
29. Burnicka-Turek O., Mohamed B.A., Shineshan K., et al. INSL5-deficient mice display an alteration in glucose homeostasis and an impaired fertility. Endocrinology 2012, 153:4655-4665.
30. Burnicka-Turek O., Shirneshan K., Paprotta I., et al. Inactivation of insulin-like factor 6 disrupts the progression of spermatogenesis at late meiotic prophase. Endocrinology 2009, 150:4348-4357.
31. Payne C.J. Cycling to and from a stem cell niche: the temporal and spatial odyssey of mitotic male germ cells. Int J Dev Biol 2013, 57(2-4):169-177.
32. Pointis G., Gilleron J., Carette D., et al. Testicular connexin 43, a precocious molecular target for the effect of environmental toxicants on male fertility. Spermatogenesis 2011, 1(4):303-317.
33. O'Donnell A.B., Travison T.G., Harris S.S., et al. Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachusetts Male Aging Study. JClin Endocrinol Metab 2006, 91(2):425-431.
34. Selby C. Sex hormone binding globulin: origin, function and clinical significance. Ann Clin Biochem 1990, 27:532-541.
35. Ashok S., Sigman M. Bioavailable testosterone should be used for the determination of androgen levels in infertile men. JUrol 2007, 177(4):1443-1446.
36. Moreno S.A., Shyam A., Morgentaler A. Comparison of free testosterone results by analog radioimmunoassay and calculated free testosterone in an ambulatory clinical population. JSex Med 2010, 7(5):1948-1953.
37. Lazarou S., Reyes-Vallejo L., Morgentaler A. Wide variability in laboratory reference values for serum testosterone. JSex Med 2006, 3(6):1085-1089.
38. Collier C.P., Clark A.F., Bain J., et al. Functional testosterone: biochemical assessment of hypogonadism in men-report from a multidisciplinary workshop hosted by the Ontario Society of Clinical Chemists. Aging Male 2007, 10(4):211-216.
39. Cangemi R., Friedmann A.J., Holloszy J.O., et al. Long-term effects of calorie restriction on serum sex-hormone concentrations in men. Aging Cell 2010, 9(2):236-242.
40. Wylie K., Froggatt N. Late onset hypogonadism, sexuality and fertility. Hum Fertil (Camb) 2010, 13(3):126-133.
41. Das M., Al-Hathal N., San-Gabriel M., et al. High prevalence of isolated sperm DNA damage in infertile men with advanced paternal age. JAssist Reprod Genet 2013, 30(6):843-848.
42. Garry P.J., Wayne S.J., Vellas B. The New Mexico aging process study (1979-2003). A longitudinal study of nutrition, health and aging. JNutr Health Aging 2007, 11(2):125-130.
43. Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 2009, 5(12):673-681.
44. Duke V.M., Winyard P.J., Thorogood P., et al. KAL, a gene mutated in Kallmann's syndrome, is expressed in the first trimester of human development. Mol Cell Endocrinol 1995, 110(1-2):73-79.
45. Layman L.C., Cohen D.P., Xie J., et al. Clinical phenotype and infertility treatment in a male with hypogonadotropic hypogonadism due to mutations Ala129Asp/Arg262Gln of the gonadotropin-releasing hormone receptor. Fertil Steril 2002, 78(6):1317-1320.
46. Trussell J.C. Male reproductive endocrinology: when to replace gonadotropins. Semin Reprod Med 2013, 31(4):237-244.
47. Augarten A., Weissenberg R., Pariente C., et al. Reversible male infertility in late onset congenital adrenal hyperplasia. JEndocrinol Invest 1991, 14(3):237-240.
48. Aksglaede L., Juul A. Testicular function and fertility in men with Klinefelter syndrome: a review. Eur J Endocrinol 2013, 168(4):R67-R76.
49. Okada H., Fujioka H., Tatsumi N., et al. Klinefelter's syndrome in the male infertility clinic. Hum Reprod 1999, 14(4):946-952.
50. López M., Torres L., Méndez J.P., et al. Clinical traits and molecular findings in 46, XX males. Clin Genet 1995, 48(1):29-34.
51. Ravizzini P. Microdissection testicular sperm extraction and IVF-ICSI outcome in nonobstructive azoospermia. Andrologia 2008, 40(4):219-226.
52. Ozkan K.U., Küçükaydin M., Muhtaroǧlu S., et al. Evaluation of contralateral testicular damage after unilateral testicular torsion by serum inhibin B levels. JPediatr Surg 2001, 36(7):1050-1053.
53. Romeo C., Impellizzeri P., Arrigo T., et al. Late hormonal function after testicular torsion. JPediatr Surg 2010, 45(2):411-413.
54. Faiman C., Hoffman D.L., Ryan R.J., et al. The "fertile eunuch" syndrome: demonstration of isolated luteinizing hormone deficiency by radioimmunoassay technique. Mayo Clin Proc 1968, 43(9):661-667.
55. Lofrano-Porto A., Casulari L.A., Nascimento P.P., et al. Effects of follicle-stimulating hormone and human chorionic gonadotropin on gonadal steroidogenesis in two siblings with a follicle-stimulating hormone beta subunit mutation. Fertil Steril 2008, 90(4):1169-1174.
56. Alexiev B.A., Alaish S.M., Sun C.C. Testicular juvenile granulosa cell tumor in a newborn: case report and review of the literature. Int J Surg Pathol 2007, 15(3):321-325.
57. Gu Y., Liang X., Wu W., et al. Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. JClin Endocrinol Metab 2009, 94:1910-1915.
58. Wang C., Leung A., Superlano L., et al. Oligozoospermia induced by exogenous testosterone is associated with normal functioning residual spermatozoa. Fertil Steril 1997, 68:149-153.
59. Patel Z.P., Niederberger C.S. Male factor assessment in infertility. Med Clin North Am 2011, 95(1):223-234.
60. Smith H.S., Elliott J.A. Opioid-induced androgen deficiency (OPIAD). Pain Physician 2012, 15(Suppl 3):ES145-ES156.
61. Fronczak C.M., Kim E.D., Barqawi A.B. The insults of illicit drug use on male fertility. JAndrol 2012, 33(4):515-528.
62. Beaton L.K., McVeigh B.L., Dillingham B.L., et al. Soy protein isolates of varying isoflavone content do not adversely affect semen quality in healthy young men. Fertil Steril 2010, 94(5):1717-1722.
63. Giwercman A. Estrogens and phytoestrogens in male infertility. Curr Opin Urol 2011, 21(6):519-526.
64. Oliveira Filho A.B., Souza R.S., Azeredo-Oliveira M.T., et al. Microdissection testicular sperm extraction causes spermatogenic alterations in the contralateral testis. Genet Mol Res 2010, 9(3):1405-1413.
65. Hammoud A.O., Gibson M., Peterson C.M., et al. Impact of male obesity on infertility: a critical review of the current literature. Fertil Steril 2008, 90(4):897-904.
66. Hassan A., Abo-Azma S.M., Fayed S.M., et al. Seminal plasma cotinine and insulin-like growth factor-I in idiopathic oligoasthenoteratozoospermic smokers. BJU Int 2009, 103(1):108-111.
67. Halls M.L., van der Westhuizen E.T., Bathgate R.A., et al. Relaxin family peptide receptors-former orphans reunite with their parent ligands to activate multiple signalling pathways. Br J Pharmacol 2007, 150(6):677-691.
68. Arai K., Chrousos G.P. Syndromes of glucocorticoid and mineralocorticoid resistance. Steroids 1995, 60(1):173-179.
69. Gabrilove J.L., Nicolis G.L., Sohval A.R. The testis in Cushing's syndrome. JUrol 1974, 112(1):95-99.
70. Dupont C., Faure C., Sermondade N., et al. Obesity leads to higher risk of sperm DNA damage in infertile patients. Asian J Androl 2013, 15:622-625.
71. Morris P.D., Channer K.S. Testosterone and cardiovascular disease in men. Asian J Androl 2012, 14(3):428-435.
72. Reis A.B., Araújo F.C., Pereira V.M., et al. Angiotensin (1-7) and its receptor Mas are expressed in the human testis: implications for male infertility. JMol Histol 2010, 41(1):75-80.
73. Mancini T., Casanueva F.F., Giustina A. Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin North Am 2008, 37(1):67-99.
74. Bolyakov A., Paduch D.A. Prolactin in men's health and disease. Curr Opin Urol 2011, 21(6):527-534.
75. Rajender S., Monica M.G., Walter L., et al. Thyroid, spermatogenesis, and male infertility. Front Biosci (Elite Ed) 2011, 3:843-855.
76. Clyde H.R., Walsh P.C., English R.W. Elevated plasma testosterone and gonadotropin levels in infertile males with hyperthyroidism. Fertil Steril 1976, 27(6):662-666.
77. Krassas G.E., Perros P. Thyroid disease and male reproductive function. JEndocrinol Invest 2003, 26(4):372-380.
78. Krassas G.E., Pontikides N. Male reproductive function in relation with thyroid alterations. Best Pract Res Clin Endocrinol Metab 2004, 18(2):183-195.
79. Shoham Z., Zalel Y., Jacobs H.S. The role of growth hormone in male infertility. Clin Endocrinol (Oxf) 1994, 41(1):1-5.
80. Andreassen M., Frystyk J., Faber J., et al. Growth hormone (GH) activity is associated with increased serum oestradiol and reduced anti-Müllerian hormone in healthy male volunteers treated with GHand a GH antagonist. Andrology 2013, 1(4):595-601.
81. Auger J., Kunstmann J.M., Czyglik F., et al. Decline in semen quality among fertile men in Paris during the past 20 years. NEngl J Med 1995, 332(5):281-285.
82. Sikka S.C., Wang R. Endocrine disruptors and estrogenic effects on male reproductive axis. Asian J Androl 2008, 10(1):134-145.
83. Rossi L., Queloz P., Brovelli A., et al. Enhancement of micropollutant degradation at the outlet of small wastewater treatment plants. PLoS One 2013, 8(3):e58864.
84. Andolz P., Bielsa M.A., Vila J. Evolution of semen quality in north-eastern Spain: a study in 22,759 infertile men over a 36 year period. Hum Reprod 1999, 14(3):731-735.
85. Cavalcanti Gde A., Leal F.D., Garrido B.C., et al. Detection of designer steroid methylstenbolone in "nutritional supplement" using gas chromatography and tandem mass spectrometry: elucidation of its urinary metabolites. Steroids 2013, 78(2):228-233.
86. Mei H., Walters C., Carter R., et al. Gpr54-/- mice show more pronounced defects in spermatogenesis than Kiss1-/- mice and improved spermatogenesis with age when exposed to dietary phytoestrogens. Reproduction 2011, 141(3):357-366.
87. Hammoud A.O., Meikle A.W., Reis L.O., et al. Obesity and male infertility: a practical approach. Semin Reprod Med 2012, 30(6):486-495.
88. Sermondade N., Massin N., Boitrelle F., et al. Sperm parameters and male fertility after bariatric surgery: three case series. Reprod Biomed Online 2012, 24(2):206-210.
89. Reis L.O., Dias F.G. Male fertility, obesity, and bariatric surgery. Reprod Sci 2012, 19(8):778-785.
90. Savastano S., Di Somma C., Pivonello R., et al. Endocrine changes (beyond diabetes) after bariatric surgery in adult life. JEndocrinol Invest 2013, 36(4):267-279.
91. Boos C.J., Simms P., Morris F.R., et al. The use of exercise and dietary supplements among British soldiers in Afghanistan. JR Army Med Corps 2011, 157(3):229-232.
92. Sussman E.M., Chudnovsky A., Niederberger C.S. Hormonal evaluation of the infertile male: has it evolved?. Urol Clin North Am 2008, 35(2):147-155.
93. Hill C.M., Anway M.D., Zirkin B.R., et al. Intratesticular androgen levels, androgen receptor localization, and androgen receptor expression in adult rat Sertoli cells. Biol Reprod 2004, 71(4):1348-1358.
94. Weeg N., Shalom-Paz E., Wiser A. Age and infertility: the clinical point of view. Minerva Ginecol 2012, 64(6):477-483.
95. Hussein A., Ozgok Y., Ross L., et al. Clomipheneadministration for cases of nonobstructive azoospermia: a multicenter study. JAndrol 2005, 26(6):787-791.
96. Reifsnyder J.E., Ramasamy R., Husseini J., et al. Role of optimizing testosterone before microdissection testicular sperm extraction in men with nonobstructive azoospermia. JUrol 2012, 188(2):532-536.
97. Hussein A., Ozgok Y., Ross L., et al. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study. BJU Int 2013, 111(3 Pt B):E110-E114.
98. Pavlovich C.P., King P., Goldstein M., et al. Evidence of a treatable endocrinopathy in infertile men. JUrol 2001, 165:837-841.
99. Raman J.D., Schlegel P.N. Aromatase inhibitors for male infertility. JUrol 2002, 167:624-629.
100. Becker T., Lipscombe L., Narod S., et al. Systematic review of bone health in older women treated with aromatase inhibitors for early-stage breast cancer. JAm Geriatr Soc 2012, 60(9):1761-1767.
101. Baykan E.K., Erdoǧan M., Ozen S., et al. Aromatase deficiency, a rare syndrome: case report. JClin Res Pediatr Endocrinol 2013, 5(2):129-132.
102. Available at:. Accessed June 1, 2013. http://reprosrx.com/androxal.php.
103. Vicari E., Mongioì A., Calogero A.E., et al. Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism-long-term follow-up. Int J Androl 1992, 15(4):320-329.
104. Kliesch S., Behre H.M., Nieschlag E. High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadal men. Eur J Endocrinol 1994, 131(4):347-354.
105. Burgués S., Calderón M.D. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism. Hum Reprod 1997, 12(5):980-986.
106. Yang L., Zhang S.X., Dong Q., et al. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience. Int Urol Nephrol 2012, 44(2):393-399.
107. Bhasin S., Cunningham G.R., Hayes F.J., Task Force, Endocrine Society, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. JClin Endocrinol Metab 2010, 95(6):2536-2559.
108. Kojima Y., Kurokawa S., Mizuno K., et al. Gene transfer to sperm and testis: future prospects of gene therapy for male infertility. Curr Gene Ther 2008, 8(2):121-134.
109. Parrington J., Coward K., Gadea J. Sperm and testis mediated DNA transfer as a means of gene therapy. Syst Biol Reprod Med 2011, 57(1-2):35-42.
110. Barker C.F., Billingham R.E. Immunologically privileged sites. Adv Immunol 1977, 25:1-54.
111. Kaur G., Long C.R., Dufour J.M. Genetically engineered immune privileged Sertoli cells: a new road to cell based gene therapy. Spermatogenesis 2012, 2(1):23-31.
112. Mital P., Kaur G., Dufour J.M. Immunoprotective Sertoli cells: making allogeneic and xenogeneic transplantation feasible. Reproduction 2010, 139(3):495-504.
113. Raya-Rivera A.M., Baez C., Atala A., et al. Tissue engineered testicular prostheses with prolonged testosterone release. World J Urol 2008, 26(4):351-358.
114. Van Saen D., Goossens E., De Block G. Regeneration of spermatogenesis by grafting testicular tissue or injecting testicular cells into the testes of sterile mice: a comparative study. Fertil Steril 2009, 91(Suppl 5):2264-2272.
115. Izadyar F., Wong J., Maki C., et al. Identification and characterization of repopulating spermatogonial stem cells from the adult human testis. Hum Reprod 2011, 26(6):1296-1306.